Lemaitre Vascular Inc (LMAT) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Lemaitre Vascular reported revenue of $249.6M, up 13.5% from $219.9M the year before. Net income was $57.7M (a 23.1% net margin), or $2.52 per diluted share. Gross margin was 71.5% and operating margin was 27.2%. Operating activities generated $81.3M of cash, leaving $74.5M of free cash flow. At fiscal year end, Lemaitre Vascular held $615.7M in total assets against $222.2M in total liabilities, including $28.2M of cash and equivalents.
Open the full interactive Lemaitre Vascular financials → Quarterly statements, key ratios, valuation history and price charts.
Lemaitre Vascular Key Stats
| Share Price | $81.55 |
|---|---|
| Market Cap | $2.00B |
| P/E Ratio | 32.4 |
| Revenue YoY Growth | +13.5% |
| 52-Week Range | $78.76 – $116.75 |
| Shares Outstanding | 22.9 million (basic, 2026 Q2) |
Lemaitre Vascular Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $129.4M | $154.4M | $161.7M | $193.5M | $219.9M | $249.6M |
| Cost of Goods Sold | $44.7M | $53.0M | $56.8M | $66.4M | $69.0M | $71.1M |
| Gross Profit | $84.6M | $101.4M | $104.9M | $127.0M | $150.9M | $178.5M |
| Operating Income | $28.8M | $36.4M | $26.8M | $36.7M | $52.3M | $67.9M |
| Pre-Tax Income | $27.4M | $34.3M | $27.5M | $39.5M | $56.9M | $75.2M |
| Income Tax | $6.1M | $7.4M | $6.9M | $9.4M | $12.8M | $17.4M |
| Net Income | $21.2M | $26.9M | $20.6M | $30.1M | $44.0M | $57.7M |
| Diluted EPS | $1.04 | $1.25 | $0.93 | $1.34 | $1.93 | $2.52 |
Lemaitre Vascular Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $61.0M | $64.5M | $66.6M | $70.4M |
| Net Income | $17.4M | $15.6M | $15.7M | $17.1M |
| Diluted EPS | $0.75 | $0.68 | $0.68 | $0.74 |
Lemaitre Vascular Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $26.8M | $13.9M | $19.1M | $24.3M | $25.6M | $28.2M |
| Current Assets | $94.3M | $139.9M | $161.7M | $194.6M | $402.2M | $468.2M |
| Total Assets | $252.8M | $292.8M | $310.5M | $346.8M | $551.8M | $615.7M |
| Current Liabilities | $25.1M | $21.8M | $25.3M | $29.9M | $30.6M | $36.3M |
| Total Long-Term Debt | $38.0M | — | — | — | $167.8M | $168.6M |
| Total Liabilities | $80.2M | $38.7M | $42.3M | $48.9M | $214.5M | $222.2M |
| Shareholders' Equity | $172.6M | $254.2M | $268.2M | $297.9M | $337.3M | $393.5M |
Lemaitre Vascular Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $34.8M | $35.1M | $25.4M | $36.8M | $44.1M | $81.3M |
| Cash From Investing | -$52.9M | -$61.1M | -$10.4M | -$24.7M | -$200.1M | -$64.9M |
| Cash From Financing | $32.2M | $13.7M | -$9.2M | -$7.1M | $158.1M | -$14.5M |
| Free Cash Flow | $31.8M | $30.2M | $22.1M | $29.5M | $37.2M | $74.5M |
Figures from Lemaitre Vascular's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Lemaitre Vascular financials page for every line item.
Lemaitre Vascular Company Profile
| Ticker | LMAT |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Burlington, Massachusetts |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001158895 |
Frequently Asked Questions
What was Lemaitre Vascular's revenue in fiscal 2025?
Lemaitre Vascular (LMAT) reported revenue of $249.6M for fiscal 2025.
What is Lemaitre Vascular's annual revenue history?
Lemaitre Vascular's annual revenue by fiscal year: 2020: $129.4M; 2021: $154.4M; 2022: $161.7M; 2023: $193.5M; 2024: $219.9M; 2025: $249.6M.
What was Lemaitre Vascular's net income in fiscal 2025?
Lemaitre Vascular reported net income of $57.7M for fiscal 2025.
What was Lemaitre Vascular's earnings per share (EPS) in fiscal 2025?
Lemaitre Vascular's diluted EPS was $2.52 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Lemaitre Vascular generate in fiscal 2025?
Lemaitre Vascular generated $74.5M of free cash flow in fiscal 2025.
What was Lemaitre Vascular's revenue last quarter?
In its most recent reported quarter (2026 Q2), Lemaitre Vascular reported revenue of $70.4M.
How much debt does Lemaitre Vascular have?
Lemaitre Vascular reported $168.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Lemaitre Vascular are outstanding?
Lemaitre Vascular reported a weighted average of 22.9 million basic shares outstanding in 2026 Q2.
What is Lemaitre Vascular's market cap?
Based on its latest closing price, Lemaitre Vascular (LMAT) has a market capitalization of about $2.00B.
When does Lemaitre Vascular's fiscal year end?
Lemaitre Vascular's fiscal year end, as registered with the SEC, is December 31.
Where is Lemaitre Vascular headquartered?
Lemaitre Vascular lists its business address in Burlington, Massachusetts in its SEC filings.
Lemaitre Vascular Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →